Letter to the Editor: Serum chitinase-3-like protein 1 as a biomarker in liver disease: Concerns regarding postoperative recurrence and hepatitis-related confounding

doi:10.4251/wjgo.124077

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 11

This Article

(7)

(6)

(0)

(178)

Peer-Review Report of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Correspondence

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Nov 15, 2026; 18(11): 124077
Published online Nov 15, 2026. doi: 10.4251/wjgo.124077

Open in New Tab Full Size Figure Download Figure

Figure 1 Receiver operating characteristic curve analysis of the diagnostic efficacy of serum chitinase-3-like protein 1 on hepatocellular carcinoma and liver cirrhosis[1]. Citation: Zhang H, Zhang R, Jia Y, Liu Y, Zhu L, Liu F, Rao H. Diagnostic value of serum chitinase-3-like protein 1 for liver fibrosis/cirrhosis and hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18: 116821. Copyright© The Authors 2026. Published by Baishideng Publishing Group. AUC: Area under the curve.

Citation: Chen CZ, Li L, Qiu JF. Letter to the Editor: Serum chitinase-3-like protein 1 as a biomarker in liver disease: Concerns regarding postoperative recurrence and hepatitis-related confounding. World J Gastrointest Oncol 2026; 18(11): 124077
URL: https://www.wjgnet.com/1948-5204/full/v18/i11/124077.htm
DOI: https://dx.doi.org/10.4251/wjgo.124077

Chen CZ, Li L, Qiu JF. Letter to the Editor: Serum chitinase-3-like protein 1 as a biomarker in liver disease: Concerns regarding postoperative recurrence and hepatitis-related confounding. World J Gastrointest Oncol 2026; 18(11): 124077 [DOI: 10.4251/wjgo.124077]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.